Xencor Appoints Bart Cornelissen as Chief Financial Officer

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today announced the appointment of Bart Cornelissen to senior vice president and chief financial officer.

Bart Cornelissen is an alumnus of RSM's MScBA.

Read the article: finance.yahoo.com/news/xencor-appoints-bart-cornelissen-chief-120100562.html

Participants

  • Bart Cornelissen
    Role: Faculty
    Reference type: Featured

Media Outlets

  • Yahoo! Finance (Online)